Vemurafenib and radiation therapy in melanoma brain metastases

By Narayana Ashwatha  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 411-416

Springer Publishing Company

Access to resources Recommend Favorite

BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF^V600E mutation

By Young Kate   Minchom Anna   Larkin James  

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 499-507

Future Medicine

Access to resources Recommend Favorite

Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia

By                

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 81-90

Spandidos Publications

Access to resources Recommend Favorite

Treatment patterns and outcomes in BRAF V600E‐mutant melanoma patients with brain metastases receiving vemurafenib in the real‐world setting

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1205-1213

John Wiley & Sons Inc

Access to resources Recommend Favorite

Melanoma

By  

Current Cancer Therapy Reviews, Vol. 12, Iss. 3, 2017-02 ,pp. : 172-203

Bentham Science Publishers

Access to resources Recommend Favorite